Hadoti Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 2.05 M
as on 24-10-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.17 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.45 Cr
as on 24-10-2024
- Revenue -8.39%
(FY 2023)
- Profit 195.06%
(FY 2023)
- Ebitda 119.68%
(FY 2023)
- Net Worth 24.54%
(FY 2023)
- Total Assets 39.80%
(FY 2023)
About Hadoti Biotech
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.05 M.
The company currently has active open charges totaling ₹2.17 Cr. The company has closed loans amounting to ₹2.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajrajeshwari Gupta and Rakesh Mittal serve as directors at the Company.
- CIN/LLPIN
U01117RJ2007PTC024493
- Company No.
024493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hadoti Biotech Private Limited offer?
Hadoti Biotech Private Limited offers a wide range of products and services, including Briquetting Machine, Coir Pith Briquetting Machine, PP Lumps, Coal, White Coal, Biomass Briquettes.
Who are the key members and board of directors at Hadoti Biotech?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rakesh Mittal | Director | 28-May-2007 | Current |
Rajrajeshwari Gupta | Director | 09-Jun-2008 | Current |
Financial Performance of Hadoti Biotech.
Hadoti Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.39% decrease. The company also saw a substantial improvement in profitability, with a 195.06% increase in profit. The company's net worth Soared by an impressive increase of 24.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hadoti Biotech?
In 2023, Hadoti Biotech had a promoter holding of 85.61% and a public holding of 14.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dynamic Goyankas Engineers Private LimitedActive 22 years 1 month
Rajrajeshwari Gupta is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of India Creation Date: 22 May 2023 | ₹1.75 M | Open |
Axis Bank Limited Creation Date: 12 Jul 2022 | ₹2.00 Cr | Open |
Central Bank Of India Creation Date: 23 Mar 2013 | ₹5.90 M | Satisfied |
How Many Employees Work at Hadoti Biotech?
Unlock and access historical data on people associated with Hadoti Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hadoti Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hadoti Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.